Edgewise Therapeutics, Inc. <EWTX.O>: H.C. Wainwright Raises Target Price to $57 From $45
EWTX•Related News
HubSpot, Inc. <HUBS.N>: Stephens Raises Target Price to $255 From $251
HUBS•
Collective Mining reports up to 74% tungsten recovery in Apollo metallurgical tests
CNL•
CDW Corp. <CDW.O>: Barclays cuts target price to $148 from $150
CDW•
Aerospace suppliers test rare-earth alternatives to ease reliance on China
XLI•
Black Hills Corp <BKH.N>: BofA Global Research raises price objective to $97.00 from $87.00
BKH•